COVID-19 vaccine procurement review says rapid access to vaccines and treatments key to on-going protection of Australians

27 September 2022 - Medicines Australia welcomes the independent review of Australia’s COVID-19 vaccine and treatment procurements by Professor Jane ...

Read more →

Halton review into vaccine and treatment procurement

27 September 2022 - Professor Jane Halton AO has handed to Government her independent review of Australia’s COVID-19 vaccine and treatment ...

Read more →

National Medicines Policy draft strides ahead but still room for improvement

26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...

Read more →

The on- and off-ramps of oncology accelerated approval

21 September 2022 - To address ongoing concerns about the implementation of the FDA’s accelerated approval pathway in oncology, a ...

Read more →

PHARMAC promises equity boost in first official response to independent review

6 September 2022 - PHARMAC will supercharge its commitment to Māori and diverse communities, which could see different medicines funded, ...

Read more →

PHARMAC releases its interim response following PHARMAC review

5 September 2022 - As part of its ongoing commitment to transparency, Te Pātaka Whaioranga – PHARMAC has today shared their ...

Read more →

Review of Efficient Funding of Chemotherapy Program - interim report

5 September 2022 - The Efficient Funding of Chemotherapy review seeks to investigate current processes involved in the production, distribution ...

Read more →

National Medicines Policy review – registrations for targeted stakeholder consultation sessions and open public forum

22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...

Read more →

Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes

18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold ...

Read more →

Accelerated approval of cancer drugs: no economic reward for drug makers that conduct confirmatory trials

17 August 2022 - The FDA uses expedited approval of drugs to speed the development and assessment of drugs that address ...

Read more →

COVID vaccine rollout too slow, poorly planned, audit finds

17 August 2022 - An audit of Australia’s coronavirus vaccination rollout has criticised the slow speed at which early doses ...

Read more →

Restart of the National Medicines Policy review – further consultation on a revised draft

17 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...

Read more →

One stop shop in Medicare shake-up

16 August 2022 - Doctors may be able to spend more time with patients, treat ­patients after-hours, and employ nurses, ...

Read more →

PHARMAC tells MPs medicine buying agency undergoing 'substantial change'

3 August 2022 - PHARMAC has undergone “substantial change” in the past few years, even before a hard hitting review ...

Read more →

PHARMAC scrutiny a win for transparency

2 August 2022 - “PHARMAC’s appearance before the Health Select Committee tomorrow morning is a triumph for transparency and the ...

Read more →